Using a Nanopatch™ to vaccinate the world (Day 276)

detailed earthI’ve talked a good deal in recent posts about novel methods of drug delivery and vaccination (see ‘Making our bodies accept drugs faster’ and ‘Injecting from the instead’) however, today’s blog is about a product that is a step closer to being adopted world-wide.

The Nanopatch™, invented by Professor Mark Kendall, started life at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology.

Marks’s Nanopatch™ idea was to offer a needle-free method of drug delivery that could be widely used and increase vaccine efficacy.

In 2011 UniQuest, the University of Queensland’s commercialisation company, helped Mark found Vaxxas to advance the possibility of Nanopatch™ becoming a clinically-proven product.

Today, Vaxxas and Mark are getting closer to making that idea a reality by raising £12.7 million of funding for a series of clinical programs and the development of a pipeline of new vaccine products for major diseases.

Continue reading Using a Nanopatch™ to vaccinate the world (Day 276)